Phylogenetic Analysis of Bovine Respiratory Syncytial Virus (BRSV) Subgroups in Wallonia Region of Belgium in Relation to Current Vaccination Strategies

<b>Background:</b> Bovine respiratory syncytial virus (BRSV) is a major pathogen of the bovine respiratory disease complex and causes regular severe winter outbreaks of respiratory disease in cattle. It is therefore responsible for important economic losses for the farming industry. In t...

Full description

Saved in:
Bibliographic Details
Main Authors: Anneliese Demil, Mickaël Dourcy, Mutien-Marie Garigliany, Dominique Cassart, Fabien Grégoire, Julien Evrard, Daniel Desmecht, Calixte Bayrou, Hani Boshra
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/13/3/298
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:<b>Background:</b> Bovine respiratory syncytial virus (BRSV) is a major pathogen of the bovine respiratory disease complex and causes regular severe winter outbreaks of respiratory disease in cattle. It is therefore responsible for important economic losses for the farming industry. In this study, the genetic diversity of the circulating BRSV strains in Belgium, which has not been assessed since the end of the 1990s, was investigated. <b>Methods</b>: We analyzed 51 BRSV-positive samples collected from 2015 to 2023. This study is the first report on the circulation of BRSV subgroup VIII in Belgium. Furthermore, co-circulation of subgroups II and III was recorded in the same period. Four commercially available vaccine strains marketed in Belgium were also included in the analysis and they clustered with subgroup II or III. <b>Results</b>: Our findings indicate that different strains of BRSV are circulating in Belgium, including those from subgroups II and VIII, with the subgroup VIII strains being particularly distant from the commercially available vaccine strains. <b>Conclusions</b>: These results highlight the importance of ensuring that the available vaccines efficiently protect against strains from circulating subgroups and assessing the potential circulation of attenuated vaccine strains.
ISSN:2076-393X